Abstract
Celiac disease (CD) has been epidemiologically associated with chronic hepatitis C (HCV), and CD activation after the initiation of interferon (IFN-α) in patients with HCV is documented. However, clear association of CD and HCV is lacking. A prospectively maintained database of 878 CD patients showed a prevalence of 0.68% (six patients). Symptoms of diarrhea, weight loss, and depression prompted the diagnosis of CD during or after IFN-α therapy in four cases. Also, 294 subjects with liver disease (195 with HCV, 80 normal controls and 19 disease controls) were prospectively screened for CD. The mean age of the subjects was 50.1 years (SD 12.3), 58% males:42% females. A total of 30% received IFN-α therapy (16% at the time of testing for CD). Two HCV patients (1%) had positive tTG-IgA but these had negative endomysial antibody (EMA) and normal duodenal biopsies. CD prevalence is not increased in patients with HCV. Routine screening of CD in HCV patients is not warranted, however, the presence of CD should be considered in the setting of clinical deterioration during or after IFN-α therapy.
Similar content being viewed by others
References
Fasano A, Catassi C (2001) Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120:636–651
Green PH, Jabri B (2003) Coeliac disease. Lancet 362:383–391
NIH Consensus Development Conference on Celiac Disease. Available at: http://www.consensus.nih.gov/2004/2004CeliacDisease118html.htm. Bethesda, Washington, DC; 2004. Accessed May 16th, 2007
Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y et al (2003) Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163:286–292
Tommasini A, Not T, Kiren V, Baldas V, Santon D, Trevisiol C, Berti I et al (2004) Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child 89:512–515
Bingley PJ, Williams AJ, Norcross AJ, Unsworth DJ, Lock RJ, Ness AR, Jones RW (2004) Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. Bmj 328:322–323
Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, Ilonen J et al (2003) Prevalence of Celiac disease among children in Finland. N Engl J Med 348:2517–2524
Logan RF, Ferguson A, Finlayson ND, Weir DG (1978) Primary biliary cirrhosis and coeliac disease: an association? Lancet 1:230–233
Dickey W, McMillan SA, Callender ME (1997) High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol 25:328–329
Kingham JG, Parker DR (1998) The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 42:120–122
Lindberg J, Ahren C, Jonsson J (1982) Gluten-free diet in chronic active hepatitis associated with intestinal villous atrophy. Hepatogastroenterology 29:52–54
Volta U, De Franceschi L, Molinaro N, Cassani F, Muratori L, Lenzi M, Bianchi FB et al (1998) Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci 43:2190–2195
Hay JE, Wiesner RH, Shorter RG, LaRusso NF, Baldus WP (1988) Primary sclerosing cholangitis and celiac disease. A novel association. Ann Intern Med 109:713–717
Brazier FDR, Sevestre H, Delamrre J, Capron J-P (1994) Primary sclerosing cholangitis and coeliac disease: beneficial effect of gluten-free diet on the liver. Eur J Gastroenterol Hepatol 6:183–186
Fracassetti O, Delvecchio G, Tambini R, Lorenzi N, Gavazzeni G (1996) Primary sclerosing cholangitis with celiac sprue: two cases. J Clin Gastroenterol 22:71–72
Gogos CA, Nikolopoulou V, Zolota V, Siampi V, Vagenakis A (1999) Autoimmune cholangitis in a patient with celiac disease: a case report and review of the literature. J Hepatol 30:321–324
Fine KD, Ogunji F, Saloum Y, Beharry S, Crippin J, Weinstein J (2001) Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol 96:138–145
Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T et al (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364
Teml A, Vogelsang H (2001) Re: Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol 96:2522–2523
Bai D, Brar P, Holleran S, Ramakrishnan R, Green PH (2005) Effect of gender on the manifestations of celiac disease: evidence for greater malabsorption in men. Scand J Gastroenterol 40:183–187
Brar P, Lee AR, Lewis SK, Bhagat G, Green PH (2006) Celiac disease in African-Americans. Dig Dis Sci 51:1012–1015
Carroccio A, Giannitrapani L, Soresi M, Not T, Iacono G, Di Rosa C, Panfili E et al (2001) Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease. Gut 49:506–511
Vecchi M, Folli C, Donato MF, Formenti S, Arosio E, de Franchis R (2003) High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source. Scand J Gastroenterol 38:50–54
Durante-Mangoni E, Iardino P, Resse M, Cesaro G, Sica A, Farzati B, Ruggiero G et al (2004) Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome. J Clin Gastroenterol 38:901–905
Germenis AE, Yiannaki EE, Zachou K, Roka V, Barbanis S, Liaskos C, Adam K et al (2005) Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. Clin Diagn Lab Immunol 12:941–948
Bourliere M, Oules V, Perrier H, Mengotti C (2001) Onset of coeliac disease and interferon treatment. Lancet 357:803–804
Nadir A, Van Thiel DH (2003) Celiac disease in patients with HCV genotype 1A. Am J Gastroenterol 98:940–941
Aguancha I, Valera JM, Hurtado C, Smok G, Brahm J (2004) Chronic hepatitis C and celiac sprue: an infrequent association. Gastroenterol Hepatol 27:408–410
Crowson AN, Nuovo G, Ferri C, Magro CM (2003) The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases. Hum Pathol 34:573–579
Adinolfi LE, Durante Mangoni E, Andreana A (2001) Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease. Am J Gastroenterol 96:607–608
Bardella MT, Marino R, Meroni PL (1999) Celiac disease during interferon treatment. Ann Intern Med 131:157–158
Cammarota G, Cuoco L, Cianci R, Pandolfi F, Gasbarrini G (2000) Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet 356:1494–1495
Martins EV Jr., Gaburri AK (2004) Celiac disease onset after pegylated interferon and ribavirin treatment of chronic hepatitis C. Arq Gastroenterol 41:132–133
Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, Nishioji K et al (1996) Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 25:283–291
Casella G, Bardella MT, Perego D, Baldini V (2004) Should routine screening for coeliac disease be considered before starting interferon/ribavirin treatment in patients affected by chronic hepatitis C? Eur J Gastroenterol Hepatol 16:429
Green PH (2005) The many faces of celiac disease: Clinical presentation of celiac disease in the adult population. Gastroenterology 128:S74–S78
Fattovich G, Giustina G, Favarato S, Ruol A (1996) A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 24:38–47
Dusheiko G (1997) Side effects of alpha interferon in chronic hepatitis C. Hepatology 26:112S–121S
Monteleone G, Pender SL, Alstead E, Hauer AC, Lionetti P, McKenzie C, MacDonald TT (2001) Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 48:425–429
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hernandez, L., Johnson, T.C., Naiyer, A.J. et al. Chronic Hepatitis C Virus and Celiac Disease, is there an Association?. Dig Dis Sci 53, 256–261 (2008). https://doi.org/10.1007/s10620-007-9851-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-007-9851-z